Publication date: Jun 10, 2019
Associate Professor Max Conway presents on using a multidisciplinary approach when treating patients with ocular melanoma at the 1st Australasian Ocular Melanoma Summit, held at the Garvan Institute of Medical Research in Sydney on May 3rd-4th, 2019.
The Australasian Ocular Melanoma Alliance (AOMA) presents the 1st Australasian Ocular Melanoma Summit. The AOMA group was founded in late 2017 by Melanoma and Skin Cancer Trials Ltd to support clinicians and researchers from all disciplines to develop, seek funding for, and collaborate on clinical trials in ocular melanoma.
Follow us at;
Australasian Ocular Melanoma Alliance – @AOMA_MASC
Melanoma and Skin Cancer Trials – @MASC_Trials
For more information contact us at firstname.lastname@example.org
The event was sponsored/supported by;
Melanoma and Skin Cancer Trials Limited, The Garvan Institute of Medical Research and Kinghorn Cancer Centre, Melanoma Institute Australia, The Save Sight Institute, SydPath and Cancer Australia.
- Radiation Oncology for Ocular Melanoma – Dr Claire Phillips
- Current Ophthalmology Treatments for Ocular Melanoma – Dr John McKenzie
- Ocular Melanoma Pathology – Dr Svetlana Cherepanoff
- CTCs and ctDNA in Ocular Melanoma – A/Prof Elin Gray
- Integrating Tumour Banking and Molecular Testing to the Diagnostic Workflow, Dr Svetlana Cherepanoff
- Oncogenic Sequencing in Uveal Melanoma Cell Lines – Dr John Park
- Whole Genome Sequencing of Ocular Melanoma – Prof Nick Hayward
- The Potential for Single Cell Sequencing in Ocular Melanoma – A/Prof Alex Swarbrick
- Food, Mood and Move in Melanoma
- BAP1: Insights and New Understandings – A/Prof Sarah Kummerfeld
- GD2-CAR-T Cell Therapy for Metastatic Uveal Melanoma – Prof Michael P. Brown